Healthcare AI Awards: Hype vs. Outcomes for Investors
In the burgeoning landscape of healthcare AI, the proliferation of innovation awards and media accolades often paints a seductive picture for investors and industry analysts.…
Viz.ai: Beyond Hype to ROI in Cardiac AI for Investors
The healthcare AI landscape is awash with bold claims and dazzling technological feats. Yet, when we at the AI Health Innovators Index assess true innovation,…
IBM Watson Health: The Billion Dollar Lesson in AI Innovation
One company amassed 5,000 patents, another published six peer-reviewed articles. This stark contrast illustrates two fundamentally different innovation archetypes in healthcare AI: the tech-first, demo-driven…
Healthcare AI’s Innovator’s Dilemma: Clinical Proof or Failure?
The promise of artificial intelligence in healthcare is vast, yet the path to impactful innovation is fraught with peril. For investors and industry analysts navigating…
Healthcare AI: 20 Companies Ranked by Substance vs Hype
The healthcare AI landscape is a minefield for investors and analysts, often shrouded in a fog of ambitious claims and dazzling press releases. How do…